美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Palvella Therapeutics

26.97

+3.3814.33%

盤後：26.970.00000.00%18:21 EDT

成交量：6.76萬

成交額：178.63萬

市值：3.03億

市盈率：-19.90

高：27.32

開：24.12

低：24.00

收：23.59

資料載入中...

總覽公司新聞公告

概念

no data

沒有相關數據

資金流向

資金流入：

資金流出：

新聞

Palvella Therapeutics Inc 報告截至 12 月 31 日的季度業績 - 收益摘要

Palvella Therapeutics Inc 預計每股虧損67美分 - 財報前瞻

嗡嗡聲--美國股票走勢-OrganiGram, Phillips 66, SurgePays

BUZZ-Stifel給予Palvella "買入 "評級，看好皮膚治療前景

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/PVLA"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PVLA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PVLA\",,,,,undefined,":{"symbol":"PVLA","market":"US","secType":"STK","nameCN":"Palvella Therapeutics","latestPrice":26.97,"timestamp":1743624000000,"preClose":23.59,"halted":0,"volume":67554,"hourTrading":{"tag":"盘后","latestPrice":26.97,"preClose":26.97,"latestTime":"18:21 EDT","volume":36,"amount":904.37,"timestamp":1743632512639},"delay":0,"floatShares":6497315,"shares":11221307,"eps":-1.355074,"marketStatus":"未開盤","change":3.38,"latestTime":"04-02 16:00:00 EDT","open":24.12,"high":27.322,"low":24,"amount":1786324.950126,"amplitude":0.140822,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-1.355074,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1743667200000},"marketStatusCode":0,"adr":0,"listingDate":1435636800000,"exchange":"NASDAQ","adjPreClose":23.59,"preHourTrading":{"tag":"盘前","latestPrice":24.69,"preClose":23.59,"latestTime":"04:48 EDT","volume":2,"amount":49.480004,"timestamp":1743583685982},"postHourTrading":{"tag":"盘后","latestPrice":26.97,"preClose":26.97,"latestTime":"18:21 EDT","volume":36,"amount":904.37,"timestamp":1743632512639},"volumeRatio":0.911955,"impliedVol":0.6703,"impliedVolPercentile":0.7333},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PVLA\",,,,,undefined,":{"symbol":"PVLA","floatShares":6497315,"roa":"--","roe":"--","lyrEps":0.679019,"volumeRatio":0.911955,"shares":11221307,"dividePrice":0,"high":27.322,"amplitude":0.140822,"preClose":23.59,"low":24,"week52Low":6.2,"pbRate":"-3.46","week52High":29.27,"institutionHeld":0,"latestPrice":26.97,"eps":-1.355074,"divideRate":0,"volume":67554,"delay":0,"ttmEps":-1.355074,"open":24.12,"prevYearClose":12,"prevWeekClose":28.1,"prevMonthClose":27.99,"prevQuarterClose":27.99,"fiveDayClose":27.93,"twentyDayClose":22.34,"sixtyDayClose":13.25},"@#url:\"https://hq.skytigris.cn/market/plate/belongs/PVLA\",params:#limit:6,delay:false,,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PVLA\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2523194226","title":"Palvella Therapeutics Inc 報告截至 12 月 31 日的季度業績 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2523194226","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523194226?lang=zh_tw&edition=fundamental","pubTime":"2025-03-31 21:31","pubTimestamp":1743427909,"startTime":"0","endTime":"0","summary":"Palvella Therapeutics Inc 报告截至 12 月 31 日的季度业绩 - 收益摘要Palvella Therapeutics Inc PVLA.OQ报告了截至12月31日的季度调整后每股亏损2.72美元，高于去年同期的每股亏损3.70美元。Palvella Therapeutics Inc 报告的季度每股收益为亏损 2.72 美元。该公司当季亏损 607 万美元。Palvella Therapeutics Inc 的股价本季度上涨了 134.2%。华尔街对 Palvella Therapeutics Inc 的 12 个月目标价中位数为 44.50 美元。)季度末预计 实际超过、达到、未达到2024 年 12 月 31 日 -0.64-2.72未达到(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250331:nL3T3QE0UM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PVLA","BK4139"],"gpt_icon":0},{"id":"2522579539","title":"Palvella Therapeutics Inc 預計每股虧損67美分 - 財報前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2522579539","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522579539?lang=zh_tw&edition=fundamental","pubTime":"2025-03-28 20:40","pubTimestamp":1743165608,"startTime":"0","endTime":"0","summary":"Palvella Therapeutics Inc 预计每股亏损67美分 - 财报前瞻Palvella Therapeutics Inc PVLA.OQ PVLA.O将于3月31日公布截至2024年12月31日的财报，预计该公司的季度收入将出现下降。华尔街对 Palvella Therapeutics Inc 的 12 个月目标价中位数为 44.00 美元，高于其最后收盘价 27.76 美元。如有任何其他问题或反馈，请联系 RefinitivNewsSupport@thomsonreuters.com。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250328:nL3S3QB0ZJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PVLA"],"gpt_icon":0},{"id":"2522538100","title":"嗡嗡聲--美國股票走勢-OrganiGram, Phillips 66, SurgePays","url":"https://stock-news.laohu8.com/highlight/detail?id=2522538100","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522538100?lang=zh_tw&edition=fundamental","pubTime":"2025-03-26 23:45","pubTimestamp":1743003917,"startTime":"0","endTime":"0","summary":".N美国东部时间11:30，道琼斯工业平均指数.DJI上涨0.06%，报42,612.53点。标准普尔500指数.SPX下跌0.54%，报5745.76点；纳斯达克综合指数.IXIC下跌1.18%，报18057.35点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250326:nL3S3Q91B9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0477156953.USD","BK4076","WOR","CTAS","SG9999001176.USD","FCX","ALNY","RIO.UK","SARO","IE00BLSP4239.USD","LU0320765059.SGD","SCCO","SPWH","ACRV","ANET","BK4130","SF","PVLA","VVPR","VVX","IE00B19Z3B42.SGD","LU0348723411.USD","MPWR","BEDU","RILY","DLTR","GWRS","SURG","LU1941712264.USD","CHWY","PTPI","BHP.AU","RIO.AU","PAYX","BK4585","IE0008368304.USD","BBIO","WVE","AEP","IE00B42XCP33.USD","PSX","WING","HUMA","JKS","GCTS"],"gpt_icon":1},{"id":"2522853713","title":"BUZZ-Stifel給予Palvella \"買入 \"評級，看好皮膚治療前景","url":"https://stock-news.laohu8.com/highlight/detail?id=2522853713","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522853713?lang=zh_tw&edition=fundamental","pubTime":"2025-03-26 22:53","pubTimestamp":1743000790,"startTime":"0","endTime":"0","summary":"BUZZ-Stifel给予Palvella \"买入 \"评级，看好皮肤治疗前景3月26日 -  ** 券商 Stifel 开始覆盖药物开发商 Palvella Therapeutics PVLA.O，给予 \"买入 \"评级，目标价 45 美元。** 新PT较该股上次收盘价上涨65  ** Stifel认为PVLA有潜力建立一个罕见皮肤病治疗组合，\"这些治疗组合的总价值可达数十亿美元\"。** Stifel 指出，该公司的凝胶 QTORIN 优化了皮肤深层的给药效果，患者耐受性高。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250326:nL3S3Q919H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PVLA"],"gpt_icon":0}],"pageSize":4,"totalPage":2,"pageCount":1,"totalSize":8}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PVLA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-03-31","symbol":"PVLA","fiscalQuarterEnding":"2024/12","expectedEps":-0.39,"name":null,"time":"盤前","type":"earning","dateTimestamp":1743393600000,"reportTimeType":"pre","actualEps":4},{"market":"US","date":"2024-11-13","symbol":"PVLA","fiscalQuarterEnding":"2024/09","expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1731474000000,"reportTimeType":"post","actualEps":-2.19},{"market":"US","date":"2024-08-14","symbol":"PVLA","fiscalQuarterEnding":"2024/06","expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1723608000000,"reportTimeType":"post","actualEps":-2.76},{"market":"US","date":"2024-05-15","symbol":"PVLA","fiscalQuarterEnding":"2024/03","expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1715745600000,"reportTimeType":"post","actualEps":-3.95},{"market":"US","date":"2024-04-23","symbol":"PVLA","defaultRemindTime":1713879000000,"type":"split","dateTimestamp":1713844800000,"forFactor":80,"toFactor":1,"ratio":80}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PVLA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PVLA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.125,"buy":0.875,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.875,"analysts":8,"updateTime":1742961600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/PVLA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"PVLA","date":"2025-04-01","current":44.513093,"percent":0.935484,"low":19.083855,"twenty":20.931809,"median":29.89804,"eighty":43.520732,"high":46.119317,"avg":30.09317,"sd":9.446978,"marketCap":314084382},"quantilePoints":[{"date":"2025-01-03","current":19.083855,"twenty":19.083855,"median":19.083855,"eighty":19.083855,"marketCap":134655684},{"date":"2025-01-10","current":22.662078,"twenty":19.083855,"median":20.077806,"eighty":23.120091,"marketCap":159903624},{"date":"2025-01-17","current":21.024047,"twenty":19.083855,"median":21.024047,"eighty":22.483962,"marketCap":148345678},{"date":"2025-01-24","current":20.658273,"twenty":19.395558,"median":20.960435,"eighty":22.003685,"marketCap":145764777},{"date":"2025-01-31","current":21.469337,"twenty":19.914003,"median":20.93658,"eighty":21.408905,"marketCap":151487644},{"date":"2025-02-07","current":23.854819,"twenty":20.19708,"median":20.960435,"eighty":22.191343,"marketCap":168319605},{"date":"2025-02-14","current":31.806426,"twenty":20.537409,"median":21.047902,"eighty":23.471552,"marketCap":224426140},{"date":"2025-02-21","current":30.216104,"twenty":20.626467,"median":21.159225,"eighty":24.999851,"marketCap":213204833},{"date":"2025-02-28","current":29.977556,"twenty":20.64237,"median":22.089563,"eighty":29.977556,"marketCap":211521636},{"date":"2025-03-07","current":38.072292,"twenty":20.658273,"median":23.043756,"eighty":30.804523,"marketCap":268638089},{"date":"2025-03-14","current":43.224933,"twenty":20.674177,"median":23.473142,"eighty":31.806426,"marketCap":304995124},{"date":"2025-03-21","current":43.622513,"twenty":20.674177,"median":24.864674,"eighty":35.527777,"marketCap":307800451},{"date":"2025-03-28","current":44.147319,"twenty":20.912725,"median":26.844623,"eighty":43.224933,"marketCap":311503482},{"date":"2025-04-01","current":44.513093,"twenty":20.931809,"median":29.89804,"eighty":43.520732,"marketCap":314084382}],"updateTime":1743654718913}}}